276 related articles for article (PubMed ID: 32118208)
1. A practical framework and online tool for mutational signature analyses show inter-tissue variation and driver dependencies.
Degasperi A; Amarante TD; Czarnecki J; Shooter S; Zou X; Glodzik D; Morganella S; Nanda AS; Badja C; Koh G; Momen SE; Georgakopoulos-Soares I; Dias JML; Young J; Memari Y; Davies H; Nik-Zainal S
Nat Cancer; 2020 Feb; 1(2):249-263. PubMed ID: 32118208
[No Abstract] [Full Text] [Related]
2. Divergence of mutational signatures in association with breast cancer subtype.
Perry G; Dadiani M; Kahana-Edwin S; Pavlovski A; Markus B; Hornung G; Balint-Lahat N; Yosepovich A; Hout-Siloni G; Jacob-Hirsch J; Sklair-Levy M; Friedman E; Barshack I; Kaufman B; Gal-Yam EN; Paluch-Shimon S
Mol Carcinog; 2022 Nov; 61(11):1056-1070. PubMed ID: 36111610
[TBL] [Abstract][Full Text] [Related]
3. Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
Poulos RC; Wong YT; Ryan R; Pang H; Wong JWH
PLoS Genet; 2018 Nov; 14(11):e1007779. PubMed ID: 30412573
[TBL] [Abstract][Full Text] [Related]
4. Modeling clinical and molecular covariates of mutational process activity in cancer.
Robinson W; Sharan R; Leiserson MDM
Bioinformatics; 2019 Jul; 35(14):i492-i500. PubMed ID: 31510643
[TBL] [Abstract][Full Text] [Related]
5. Substitution mutational signatures in whole-genome-sequenced cancers in the UK population.
Degasperi A; Zou X; Amarante TD; Martinez-Martinez A; Koh GCC; Dias JML; Heskin L; Chmelova L; Rinaldi G; Wang VYW; Nanda AS; Bernstein A; Momen SE; Young J; Perez-Gil D; Memari Y; Badja C; Shooter S; Czarnecki J; Brown MA; Davies HR; ; Nik-Zainal S
Science; 2022 Apr; 376(6591):. PubMed ID: 35949260
[TBL] [Abstract][Full Text] [Related]
6. A practical framework RNMF for exploring the association between mutational signatures and genes using gene cumulative contribution abundance.
Li Z; Liang H; Zhang S; Luo W
Cancer Med; 2022 Nov; 11(21):4053-4069. PubMed ID: 35575002
[TBL] [Abstract][Full Text] [Related]
7. Mutational burden and signatures in 4000 Japanese cancers provide insights into tumorigenesis and response to therapy.
Hatakeyama K; Nagashima T; Ohshima K; Ohnami S; Ohnami S; Shimoda Y; Serizawa M; Maruyama K; Naruoka A; Akiyama Y; Urakami K; Kusuhara M; Mochizuki T; Yamaguchi K
Cancer Sci; 2019 Aug; 110(8):2620-2628. PubMed ID: 31152682
[TBL] [Abstract][Full Text] [Related]
8. A Simple Model-Based Approach to Inferring and Visualizing Cancer Mutation Signatures.
Shiraishi Y; Tremmel G; Miyano S; Stephens M
PLoS Genet; 2015 Dec; 11(12):e1005657. PubMed ID: 26630308
[TBL] [Abstract][Full Text] [Related]
9. Assigning mutational signatures to individual samples and individual somatic mutations with SigProfilerAssignment.
Díaz-Gay M; Vangara R; Barnes M; Wang X; Islam SMA; Vermes I; Duke S; Narasimman NB; Yang T; Jiang Z; Moody S; Senkin S; Brennan P; Stratton MR; Alexandrov LB
Bioinformatics; 2023 Dec; 39(12):. PubMed ID: 38096571
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile.
Smid M; Schmidt MK; Prager-van der Smissen WJC; Ruigrok-Ritstier K; Schreurs MAC; Cornelissen S; Garcia AM; Broeks A; Timmermans AM; Trapman-Jansen AMAC; Collée JM; Adank MA; Hooning MJ; Martens JWM; Hollestelle A
Breast Cancer Res; 2023 May; 25(1):53. PubMed ID: 37161532
[TBL] [Abstract][Full Text] [Related]
11. Patterns and processes of somatic mutations in nine major cancers.
Jia P; Pao W; Zhao Z
BMC Med Genomics; 2014 Feb; 7():11. PubMed ID: 24552141
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis reveals distinct mutational signature and its mechanistic insights of alcohol consumption in human cancers.
Wei R; Li P; He F; Wei G; Zhou Z; Su Z; Ni T
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32480415
[TBL] [Abstract][Full Text] [Related]
13. Mutational Signatures in Cancer (MuSiCa): a web application to implement mutational signatures analysis in cancer samples.
Díaz-Gay M; Vila-Casadesús M; Franch-Expósito S; Hernández-Illán E; Lozano JJ; Castellví-Bel S
BMC Bioinformatics; 2018 Jun; 19(1):224. PubMed ID: 29898651
[TBL] [Abstract][Full Text] [Related]
14. Accurate and sensitive mutational signature analysis with MuSiCal.
Jin H; Gulhan DC; Geiger B; Ben-Isvy D; Geng D; Ljungström V; Park PJ
Nat Genet; 2024 Mar; 56(3):541-552. PubMed ID: 38361034
[TBL] [Abstract][Full Text] [Related]
15. Analysis of mutational signatures with yet another package for signature analysis.
Hübschmann D; Jopp-Saile L; Andresen C; Krämer S; Gu Z; Heilig CE; Kreutzfeldt S; Teleanu V; Fröhling S; Eils R; Schlesner M
Genes Chromosomes Cancer; 2021 May; 60(5):314-331. PubMed ID: 33222322
[TBL] [Abstract][Full Text] [Related]
16. Mutational signatures of colorectal cancers according to distinct computational workflows.
Battuello P; Corti G; Bartolini A; Lorenzato A; Sogari A; Russo M; Di Nicolantonio F; Bardelli A; Crisafulli G
Brief Bioinform; 2024 May; 25(4):. PubMed ID: 38783705
[TBL] [Abstract][Full Text] [Related]
17. Whole exome sequencing-based analysis to identify DNA damage repair deficiency as a major contributor to gliomagenesis in adult diffuse gliomas.
Ülgen E; Can Ö; Bilguvar K; Oktay Y; Akyerli CB; Danyeli AE; Yakıcıer MC; Sezerman OU; Pamir MN; Özduman K
J Neurosurg; 2019 Apr; 132(5):1435-1446. PubMed ID: 30952131
[TBL] [Abstract][Full Text] [Related]
18. Mutational signatures reveal ternary relationships between homologous recombination repair, APOBEC, and mismatch repair in gynecological cancers.
Farmanbar A; Firouzi S; Kneller R; Khiabanian H
J Transl Med; 2022 Feb; 20(1):65. PubMed ID: 35109853
[TBL] [Abstract][Full Text] [Related]
19. Mutational signature assignment heterogeneity is widespread and can be addressed by ensemble approaches.
Wu AJ; Perera A; Kularatnarajah L; Korsakova A; Pitt JJ
Brief Bioinform; 2023 Sep; 24(6):. PubMed ID: 37742051
[TBL] [Abstract][Full Text] [Related]
20. Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression.
Ashley CW; Da Cruz Paula A; Kumar R; Mandelker D; Pei X; Riaz N; Reis-Filho JS; Weigelt B
Gynecol Oncol; 2019 Jan; 152(1):11-19. PubMed ID: 30415991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
